Related Experiment Video
Updated: Jun 2, 2026

07:27
Simplified Whole Body Plethysmography to Characterize Lung Function During Respiratory Melioidosis
Published on: February 24, 2023
Pulmonary melioidosis in Cambodia: a prospective study
Blandine Rammaert1, Julien Beauté, Laurence Borand
1Institut Pasteur - Cambodia, Phnom Penh, Cambodia.
BMC Infectious Diseases
|May 17, 2011
Summary
Melioidosis, a disease caused by Burkholderia pseudomallei, has a high fatality rate in Cambodia due to limited access to effective antibiotics and under-recognition. This study highlights the critical need for improved diagnosis and treatment strategies for this endemic infection.
Area of Science:
- Infectious Diseases
- Tropical Medicine
- Public Health
Background:
- Melioidosis, caused by Burkholderia pseudomallei, is endemic in Southeast Asia but poorly documented in Cambodia.
- This study reports the first series of hospitalized pulmonary melioidosis cases in Cambodia.
Purpose of the Study:
- To describe the clinical characteristics and outcomes of melioidosis patients in Cambodia.
- To assess the cost-of-illness and long-term outcomes of melioidosis.
Main Methods:
- Surveillance of acute lower respiratory infections (ALRI) in two provincial hospitals.
- Detection of B. pseudomallei in sputum or blood cultures.
- Follow-up of cases for 6 months to 2 years post-discharge.
Main Results:
- 39 ALRI cases with melioidosis identified between 2007-2010, with a median age of 46 years and 56.4% males.
- High mortality rate (61.5%), with most deaths occurring early and often without effective antibiotics.
- Significant financial burden on patients, with many incurring debt or selling assets.
Conclusions:
- High fatality rate attributed to lack of effective antibiotics and under-recognition by clinicians.
- Inappropriate therapy due to delayed or missed diagnosis contributes to poor outcomes.
- Urgent need for improved diagnostic and therapeutic strategies for melioidosis in Cambodia.
Related Concept Videos
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
